// April 18, 2024
USP’s commitment to ESG considerations for a healthier, more sustainable world
At the U.S.
At the U.S.
Another public health crisis looms in the wake of the COVID-19 pandemic.
With significant innovations in pharmaceuticals, including biologic drugs